Lodo Therapeutics
New York, US · Founded 2015 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
DS
David SchubertExecutive Officer, Promoter
JM
Joel MarcusDirector
LR
Lindsay RayleExecutive Officer, Promoter
BD
Barbara DaltonDirector
SG
Steve GillisDirector
DP
David PomplianoExecutive Officer
MJ
M. Johnston ErwinDirector
TL
Thong LeExecutive Officer, Director, Promoter
DM
David McElligottExecutive Officer, Promoter
AX
Asish XavierDirector
JS
James SullivanDirector
MU
Misti UshioDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$19.9MraisedJan 2017 · 13 investors · BiotechnologyRule 506(b)
▶$19.9MraisedJan 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchubertExecutive Officer, Promoter
- Joel MarcusDirector
- Lindsay RayleExecutive Officer, Promoter
- Barbara DaltonDirector
- Steve GillisDirector
- David PomplianoExecutive Officer
- M. Johnston ErwinDirector
- Misti UshioDirector
- Thong LeExecutive Officer, Director, Promoter
- David McElligottExecutive Officer, Promoter
- Asish XavierDirector
- James SullivanDirector
- Offering amount
- $19.9M
- Amount sold
- $19.9M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.